scholarly article | Q13442814 |
P50 | author | Krzysztof Bartuś | Q114079238 |
P2093 | author name string | B Pigott | |
J Garthwaite | |||
P2860 | cites work | Potent, Highly Selective, and Orally Bioavailable Gem -Difluorinated Monocationic Inhibitors of Neuronal Nitric Oxide Synthase | Q27664466 |
Intramolecular hydrogen bonding: A potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase | Q27677512 | ||
Nitric oxide synthases: structure, function and inhibition | Q28207668 | ||
Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats | Q28271665 | ||
Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance | Q28294344 | ||
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine | Q29547539 | ||
Nitric oxide and macrophage function | Q29615327 | ||
The influence of nitric oxide synthase 1 on blood flow and interstitial nitric oxide in the kidney | Q30992238 | ||
Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria | Q31442574 | ||
Inhibition of nitric oxide synthase as a potential therapeutic target | Q33636670 | ||
Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeability | Q33638377 | ||
Guide to Receptors and Channels (GRAC), 5th edition | Q34228968 | ||
Tonic and phasic nitric oxide signals in hippocampal long-term potentiation. | Q34580308 | ||
Activities of 7-nitroindazole and 1-(2-(trifluoromethylphenyl)-imidazole independent of neuronal nitric-oxide synthase inhibition | Q34749486 | ||
Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase | Q34770661 | ||
Effects of Cerebral Ischemia in Mice Deficient in Neuronal Nitric Oxide Synthase | Q71647466 | ||
Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline | Q71650800 | ||
The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes | Q73097957 | ||
Discovery and development of neuronal nitric oxide synthase inhibitors | Q74114991 | ||
N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase | Q74424557 | ||
Design of isoform-selective inhibitors of nitric oxide synthase | Q77297321 | ||
Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities | Q82994594 | ||
Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS | Q84719163 | ||
The neuronal NO synthase participation in the peripheral antinociception mechanism induced by several analgesic drugs | Q84850873 | ||
More than a retrograde messenger: nitric oxide needs two cGMP pathways to induce hippocampal long-term potentiation. | Q34993540 | ||
Blocking NO synthesis: how, where and why? | Q35013972 | ||
Central nicotinic acetylcholine receptor involved in Ca(2+) -calmodulin-endothelial nitric oxide synthase pathway modulated hypotensive effects. | Q35130526 | ||
Amelioration of renal injury and oxidative stress by the nNOS inhibitor L-VNIO in the salt-sensitive mRen2.Lewis congenic rat. | Q36013066 | ||
Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine | Q36817052 | ||
Concepts of neural nitric oxide-mediated transmission | Q37029494 | ||
Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping. | Q37147032 | ||
A cellular model for screening neuronal nitric oxide synthase inhibitors | Q37207509 | ||
PP2B-dependent NO production in the medullary thick ascending limb during diabetes | Q37298520 | ||
Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability | Q37416111 | ||
The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models | Q37563705 | ||
Picomolar nitric oxide signals from central neurons recorded using ultrasensitive detector cells. | Q39455068 | ||
The effect of nNOS inhibitors on toxin-induced cell death in dopaminergic cell lines depends on the extent of enzyme expression. | Q39511180 | ||
Guidelines for reporting experiments involving animals: the ARRIVE guidelines | Q39512979 | ||
Supersensitivity to the cyclic GMP response to glutamate during cerebellar maturation | Q40173230 | ||
L-arginine binding to nitric-oxide synthase. The role of H-bonds to the nonreactive guanidinium nitrogens | Q40932895 | ||
Induction and expression of GluA1 (GluR-A)-independent LTP in the hippocampus | Q41502449 | ||
Differential effects of nitric oxide synthase inhibitors on endothelium-dependent and nitrergic nerve-mediated vasodilatation in the bovine ciliary artery | Q41786597 | ||
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway | Q41811038 | ||
Hypertension in mice lacking the gene for endothelial nitric oxide synthase | Q42478091 | ||
Presynaptic nitric oxide/cGMP facilitates glutamate release via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus | Q42485358 | ||
Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-L-arginine | Q42546131 | ||
1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo | Q42551195 | ||
The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse | Q42707876 | ||
Direct blockade of inflammatory hypernociception by peripheral A1 adenosine receptors: involvement of the NO/cGMP/PKG/KATP signaling pathway | Q42919200 | ||
Role of endothelial nitric oxide synthase in aggravation of indomethacin-induced gastric damage in adjuvant arthritic rats. | Q43197254 | ||
The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. | Q43517525 | ||
Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice | Q43799971 | ||
Enhanced neuronal nitric oxide synthase expression is central to cardiac vagal phenotype in exercise-trained mice | Q44267764 | ||
The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Q45104121 | ||
Roles of nitric oxide in the homeostatic control of the excitation-inhibition balance in rat visual cortical networks. | Q45932639 | ||
The opposite roles of nNOS in cardiac ischemia-reperfusion-induced injury and in ischemia preconditioning-induced cardioprotection in mice | Q46064498 | ||
Neuronal nitric oxide synthase activation is involved in insulin-mediated cardiovascular effects in the nucleus tractus solitarii of rats | Q46148829 | ||
Brown Norway rats show impaired nNOS-mediated information transfer in renal autoregulation | Q46164237 | ||
Nitric oxide is a volume transmitter regulating postsynaptic excitability at a glutamatergic synapse | Q46225669 | ||
Structure-activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: alkenyl-amidines as new leads. | Q46243381 | ||
Neuronal nitric-oxide synthase inhibition facilitates adrenergic neurotransmission in rat mesenteric resistance arteries | Q46763770 | ||
Tubuloglomerular feedback-dependent modulation of renal myogenic autoregulation by nitric oxide | Q46809194 | ||
mRNA expression patterns of the cGMP‐hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain | Q47378008 | ||
Norepinephrine increases cyclic GMP levels in cerebellar cells from neuronal nitric oxide synthase knockout mice | Q47903375 | ||
NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway | Q48795375 | ||
Excitatory amino acid receptors and guanosine 3',5'-cyclic monophosphate in incubated slices of immature and adult rat cerebellum | Q48894532 | ||
Nanomolar N(G)-nitroarginine inhibits NMDA-induced cyclic GMP formation in rat cerebellum | Q48919196 | ||
The selective neuronal NO synthase inhibitor 7-nitro-indazole blocks both long-term potentiation and depotentiation of field EPSPs in rat hippocampal CA1 in vivo. | Q51584368 | ||
Targeted disruption of the neuronal nitric oxide synthase gene. | Q52507290 | ||
NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices | Q69359908 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1255-1265 | |
P577 | publication date | 2013-03-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | On the selectivity of neuronal NOS inhibitors | |
P478 | volume | 168 |
Q33668740 | Association of endothelial nitric oxide synthase polymorphisms with an increased risk of erectile dysfunction |
Q89952047 | Correction of arginine metabolism with sepiapterin-the precursor of nitric oxide synthase cofactor BH4-induces immunostimulatory-shift of breast cancer |
Q37575908 | Inducible nitric oxide synthase inhibits oxygen consumption in collateral-dependent myocardium |
Q41815879 | Nitric Oxide Is Required for L-Type Ca(2+) Channel-Dependent Long-Term Potentiation in the Hippocampus |
Q42467382 | Nitric oxide targets oligodendrocytes and promotes their morphological differentiation |
Q37150793 | Nitric oxide-dependent long-term depression but not endocannabinoid-mediated long-term potentiation is crucial for visual recognition memory |
Q41087764 | Preinduction of heat shock protein 70 protects mice against post-infection irritable bowel syndrome via NF-κB and NOS/NO signaling pathways |
Q64080512 | Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβ |
Q39103641 | Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders |
Q100443906 | nNOS-expressing interneurons control basal and behaviorally evoked arterial dilation in somatosensory cortex of mice |
Search more.